Clinical Trial Update: Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial tested the combination of docetaxel, 5-fluorouracil, and oxaliplatin in patients with gastric cancer or gastroesophageal junction ade…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Gastrointestinal Diseases | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-10-31